BMS Sues Merck As Soon As USPTO Grants Cancer Patent
Bristol-Myers Squibb Co. went after Merck and Co. in Delaware federal court Tuesday for allegedly infringing on its immunotherapy cancer treatment, filing the suit on the same day that the U.S....To view the full article, register now.
Already a subscriber? Click here to view full article